Eight new alkaloids, including three pairs of enantiomers (+)-(2 0 S,3 0 R)-clauselansine A (1a) and (À)-(2 0 R,3 0 S)clauselansine A (1b); (+)-(2 0 S,3 0 R)-clauselansine B (2a) and (À)-(2 0 R,3 0 S)-clauselansine B (2b);
Introduction
Clausena is a small genus within the family Rutaceae, which is distributed throughout the south of the Yangtze River in china, such as the Yunnan, Guangxi and Guangdong regions. 1 Previous phytochemical studies have revealed that the Clausena genus contains a wide variety of carbazole alkaloids, amide alkaloids, coumarins, and limonoids, many of which possess various pharmacological properties such as antibacterial, anti-inammatory, anti-HIV, cytotoxic, hepatoprotective and neuroprotective effects. [2] [3] [4] [5] [6] [7] [8] [9] [10] The leaves and fruits of Clausena lansium, Clausena excavata, Clausena emarginata, and Clausena anisum-molens are not only eaten as food but also used for traditional medicine.
Clausena lansium (Lour.) Skeels (Rutaceae), a fruit tree, was widely distributed in southern China. In traditional Chinese medicine, the leaves and roots of C. lansium were used for cough, asthma, dermatological disease, viral hepatitis, and gastro-intestinal diseases; the seeds are used to treat acute and chronic gastro-intestinal inammation, ulcers, etc. 11 Various bioactive constituents including coumarins, carbazole alkaloids and amide alkaloids have been isolated and identied from this plant. [12] [13] [14] Previously, twenty new natural products including thirteen new carbazole alkaloids, 10, 15 eight alkaloid glycosides, 16 four new coumarins, 17 a new amide and a new megastigmane glucoside 18 from the leaves and skeels of C. lansium were reported by our research group, and some of these alkaloids showed selective neuroprotective effects. In order to investigate the potential neuroprotective constituents from different parts of C. lansium, n-BuOH extract of the stems of this plant were selected for investigation. This paper reported further investigation of n-BuOH extract from the stems of C. lansium which led to the isolation and characterization of four new indole alkaloids (1a, 1b, 2a, 2b), two new amide alkaloids (3a, 3b), and two carbazole alkaloids (4a, 5a) along with twelve known compounds (4b, 5b, 6a, 6b, 7a, 7b, [8] [9] [10] [11] [12] [13] from the stems of C. lansium. The neuroprotective activities of 1-13 were also evaluated. We present herein the isolation and structural characterization of 1-13, as well as their bioactivities (Fig. 1 ).
trisubstituted benzene ring at 7.43 (1H, d, J ¼ 7. 6 Hz, H-4), 6 .90 (1H, t, J ¼ 7.4 Hz, H-5), 6.85 (1H, d, J ¼ 6. 8 Hz, H-6), together with a doublet at d H 7.18 (1H, d, J ¼ 2.4 Hz, H-2) and a broad signal at d H 10.80 (1H, NH), which indicated a 3,7-disubstituted indole moiety. In addition, a double bond group at d H 5.66 (1H, t, J ¼ 7.3 Hz, H-2 00 ), a methylene at 3.55 (2H, d, J ¼ 7.3 Hz, H-1 00 ) and two methyls at d H 1.70 (3H, s, H-5 00 ), 1.00 (3H, s, H-5 0 ) were also exhibited in the 1 H NMR spectrum. The 13 C NMR and DEPT spectra exhibited a double bond, and four methylenes, two methines, two methyls and the remaining eight in indole moiety. The above information indicated 1 was a diprenylated indole. A comparison of the 1 H and 13 C NMR of 1 with those of hexalobines 19 suggested that their structures are closely related, except for 1,3,4-trihydroxy-3-methylbut-2-yl and 4-hydroxy-3methyl-2-butenyl at C-3 and C-7 in 1. In the HMBC spectrum, the cross-peaks between H-1 0 /C-3 (d C 114.2), C-3 0 (d C 75.0), H-2 0 / C-2 (d C 123.0), C-3a (d C 128.3), C-5 0 (d C 22.0), H-4 0 /C-3 0 (d C 75.0), C-5 0 (d C 22.0) demonstrated 1,3,4-trihydroxy-3-methylbut-2-yl group attached to C-3 of the indole moiety ( Fig. 2) ; the crosspeaks between H-1 00 /C-6 (d C 119.7), C-7a (d C 134.4), C-3 00 (d C 136.3), H-2 00 /C-7 (d C 123.7), C-4 00 (d C 66.3), C-5 00 (d C 13.7) demonstrated 4-hydroxy-3-methyl-2-butenyl group attached to C-7 of the indole moiety (Fig. 2 ). The NOE difference experiment displayed that a strong enhancement of H-2 00 was observed when H-4 00 was irradiated while H-2 00 was no enhanced on irradiation of H-5 00 , indicating an E conguration of the double bond. Thus, the structure of 1 was elucidated. The specic rotation of 1 approached zero, and no Cotton effect was found in the electronic circular dichroism (ECD) spectrum of 1, indicating a racemic mixture. Subsequent chiral resolution of 1 afforded the anticipated enantiomers 1a and 1b, which showed mirror image-like ECD curves and specic rotations {1a:
[a] 20 D +18.7 (c 0.1 MeOH); 1b: [a] 20 D À17.0 (c 0.1 MeOH)}. In order to conrm the absolute conguration of the 1 0 ,3 0 ,4 0 -triol of 1b, 1b was treated with 2,2-dimethoxypropane and pyridinium p-toluene sulfonate and converted into its acetonide 1c ( Fig. 3 ). According to 1D and 2D NMR, 1c was determined similar to pyrido [3,4-b] pyrano [3,4-b] indoles. 20 In order to conrm the absolute conguration of 1c, the ECD calculations were also performed for the four congurations 2 0 R,3 0 S-, 2 0 R,3 0 R-, 2 0 S,3 0 R-, and 2 0 S,3 0 S-1c using the time-dependent density functional theory (TDDFT) method at the B 3 LYP/6-31G (d) level. 21, 22 The calculated ECD spectrum for 2 0 R,3 0 S-and 2 0 R,3 0 R-1c enantiomer agreed with the experimental ECD data ( Fig. 4 ) of 1c. Thus, the absolute conguration at C-2 0 of 1c was 2 0 R. In addition, the absolute conguration of the 3 0 ,4 0 -diol moiety of 1c was determined using induced CD spectra by Snatzke's method. 23, 24 A positive Cotton effect at 323 nm ( Fig. 5 ) in the induced CD spectrum indicated the 3 0 S conguration for 1c by means of the empirical helicity rule. According to the above information, the absolute conguration of 1b was 2 0 R,3 0 S, and then the absolute conguration of 1a was 2 0 S,3 0 R. Therefore, compounds 1a and 1b were given the trivial names (+)-(2 0 S,3 0 R)-clauselansine A and (À)-(2 0 R,3 0 S)-clauselansine A, respectively.
Compound 2 (2a/2b) was obtained as a white powder. Its molecular formula C 18 H 23 NO 3 was deduced from the HRESIMS (m/z 302.1758 [M + H] + , calcd for C 18 H 24 NO 3 , 302.1751) and 13 C NMR spectroscopic data, corresponding with eight indices of hydrogen deciency. The 1 H and 13 C NMR of 2 displayed signals characteristic of diprenylated indole, which were similar to these reported for compound 1. The only difference between 2 and 1 was that OH-1 0 and OH-4 0 of 1,3,4-trihydroxy-3-methylbut-2-yl group in 1 is formed ve-membered oxygen ring in 2. This was supported further by the HMBC correlations between H-1 0 (d H 4.02) and C-4 0 (d C 80.5) and H-4 0 (d H 3.79) and C-1 0 (d C 71.8). The NOE difference experiment displayed that a strong enhancement of H-2 00 was observed when H-4 00 was irradiated, while H-2 00 was no enhanced on irradiation of H-5 00 , indicating an E conguration of the double bond. Thus, the structure of 2 was elucidated.
The specic rotation of 2 approached zero, and no Cotton effect was found in the electronic circular dichroism (ECD) spectrum of 2, indicating a racemic mixture. Subsequent chiral resolution of 2 afforded the anticipated enantiomers 2a and 2b, which showed mirror image-like ECD curves and specic rotations {2a: [a] 20 D +28.0 (c 0.1 MeOH); 2b: [a] 20 D À32.6 (c 0.1 MeOH)}. In order to conrm the absolute conguration of the enantiomers 2a and 2b, a systematic conformational analysis and optimization were performed for 2a and 2b using the same method applied to 1a and 1b. A comparison of the theoretically calculated and experimental ECD curves (Fig. 6 ) demonstrated that the conguration of 2a was 2 0 S,3 0 R and the conguration of 2b was 2 0 R,3 0 S. According to the structures of 1a and 2a, we speculate that 2a was possibly generated by dehydration of 1a, which means the conguration of 2a was the same as 1a. And 2b was also possibly generated by dehydration of 1b, which means the conguration of 2b was the same as 1b. Thus, 2a has a 2 0 S,3 0 R-conguration and 2b has a 2 0 R,3 0 S-conguration. Therefore, compounds 2a and 2b were given the trivial names (+)-(2 0 S,3 0 R)-clauselansine B and (+)-(2 0 R,3 0 S)-clauselansine B, respectively. Compound 3 (3a/3b) was obtained as a white solid. Its molecular formula was assigned as C 18 H 17 NO 2 based on the 13 C NMR spectroscopic data and HRESIMS (m/z 280.1333 [M + Na] + , calcd for C 18 H 17 NO 2 Na, 280.1332), implying eleven indices of hydrogen deciency. The IR spectrum displayed absorptions characteristic of hydroxyl (3320 cm À1 ), carbonyl (1678 cm À1 ) and aromatic groups (1601, 1483, and 1454 cm À1 ). The 1 H NMR spectrum showed nine aromatic protons [ring A: d H 6.92 (1H, d, J ¼ 7.6 Hz, H-3 0 ), 7.23 (1H, overlapped, H-4 0 ), 7.31 (1H, m, H-5 0 ) and 6.23 (1H, d, J ¼ 7.6 Hz, H-6 0 ); ring B: d H 6.98 (2H, d, J ¼ 7.1 Hz, H-2 00 , 6 00 ), 7.27 (2H, m, H-3 00 , 5 00 ), 7.23 (1H, overlapped, H-4 00 )], together with four methine groups at d Table 2 ) also indicated 1,2-disubstituted and monosubstituted aromatic units (ring A and B) and one methyl group. The HMBC correlations ( Fig. 6 ) of H-4 with C-2 0 (d C 144.7) and C-6 0 (d C 124.3); H-5 with C-2 0 (d C 144.7) and C-1 00 (d C 140.7); H-6 with C-3 0 (d C 125.8) and C-2 00 /C-6 00 (d C 129.6) showed that ring A was connected at C-4 and C-6, and ring B was connected at C-6. The above information coupled with biogenetic considerations and literature references indicated 3 was similar to the dehydro-derivative of neoclausenamide. 25, 26 Its relative conguration was established on the basis of NOESY correlations (Fig. 7) . The NOESY correlations of H-4 with H-5, H-5 with H-4, H-6, N-CH 3 and H-6 with H-5, H-6 00 , H-3 with H-2 00 showed that H-4, H-5 and H-6 were b orientation, while H-3 was a orientation. Thus, compound 3 (clauselansine C) was fully identied. The specic rotation of 3 approached zero, and no Cotton effect was found in the electronic circular dichroism (ECD) spectrum of 3, indicating a racemic mixture. Subsequent chiral resolution of 3 afforded the anticipated enantiomers 3a and 3b, which showed mirror image-like ECD curves and specic rotations {3a: [a] 20 D +17.9 (c 0.1 MeOH); 3b: [a] 20 D À22.0 (c 0.1 MeOH)}. Compound 3a was treated with (R)-and (S)-a-methoxy-a-(tri-uoromethyl)phenylacetyl chloride (MTPA-Cl) in anhydrous CH 2 Cl 2 to afforded the 3a-(S)-MTPA ester (3aa) and 3a-(R)-MTPA ester (3ab), respectively. The Dd SR H values were calculated as shown in Fig. 8 . Application of Mosher's rule 27 revealed that 3a had the 3S,4R,5S,6S conguration. Meanwhile, the absolute conguration of 3b was assigned with the 3R,4S,5R,6R-conguration. In order to conrm the absolute conguration of the enantiomers 3a and 3b, the ECD calculations were also performed for the two congurations 3S,4R,5S,6S-and 3R,4S,5R,6R-3 using the time-dependent density functional theory (TDDFT) method at the B 3 LYP/6-31G (d) level. 21, 22 The calculated ECD spectrum for 3S,4R,5S,6S-3 agreed with the experimental ECD data ( Fig. 9 ) of 3a. The calculated ECD spectrum for 3R,4S,5R,6R-3 was in good accordance with the experimental spectrum of 3b ( Fig. 9 ). Thus, 3a has a 3S,4R,5S,6S conguration and 3b has a 3R,4S,5R,6R conguration. Therefore, compounds 3a and 3b were given the trivial names (+)-(3S,4R,5S,6S)-clauselansine C and (À)-(3R,4S,5R,6R)-clauselansine C, respectively.
Compound 4 (4a/4b) was obtained as a white powder. Its molecular formula was determined as C 19 (Table 3) 
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which had opposite ECD curves (Fig. 11) . The absolute congurations of 5a and 5b were determined using the same methods as described in 4a and 4b. Thus, 5a was dened as (+)-(1 0 R,2 0 R)claulansine D, and 5b was identied as the known compound (À)-(1 0 S,2 0 S)-claulansine D. The structures of nine known compounds were also identi-ed by comparing their spectroscopic data to those found in the literature. The known compounds isolated were claulansine B (4b), 10 claulansine D (5b), 10 (À)-(1S,3S)-1-methyl-1,2,3,4-tetrahydro-b-carboline-3-carboxylic acid (6a), 28 (+)-(1R,3S)-1-methyl-1,2,3,4-tetrahydro-b-carboline-3-carboxylic acid (6b), 28 (R)-isoplatydesmine (7a), 29 (S)-isoplatydesmine (7b), 30 claulansine A (8), 10 ribalinine (9), 31 g-fagarine (10), 32 dictamnine (11), 33 N-(2hydroxy-2-phenylethyl)-cinnamamide (12) , 34 N-phenylethylbenzamide (13). 34 Compounds 1-13 were evaluated for their neuroprotective effect on neuron-like PC12 cells induced by Ab [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] , and Okadaic Acid (OKA) in vitro using the MTT method. The neuron growth factor (NGF) was used as a positive control. At 10 mM, 1b, 2a, 3b, 5a, 5b increased the cell survival rate of the Okadaic acid-treated group, other compounds were inactive, while all the compounds failed to protect cells from Ab [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] .
Clausenamide is one of novel compounds isolated from Clausena lansium (Lour) skeels. Clausenamide is unusual in that it contains 4 chiral centers yielding 8 pairs of enantiomers. In pharmacological studies numerous models and indicators showed that (À)-clausenamide is the active enantiomer, while (+)-clausenamide is inactive and elicits greater toxicity than (À)-clausenamide. 35 Compounds 3 and clausenamide are very similar in structure and therefore have the same biological activity. Similarly, 3b is the active enantiomer, while 3a is inactive. The carbazole and quinolone alkaloids having neuroprotective effects were exhibited in previous researches, 10, 36 and carbazole alkaloids may derived from indole alkaloids. As we all know, thalidomide as a chiral racemic compound, its R-conguration has inhibitory activity of pregnancy, while S-conguration has teratogenic. One of the isomers of the enantiomer is highly active and the other isomer is inactive, or both isomers are active, or both isomers are inactive. Thus, it's reasonable that compound 1b, 2a, 5a, and 5b are active while 1a, 2b are inactive. All in all, alkaloids isolated from C. lansium are worthy of study to nd more potential effects in the further ( Table 4 ).
Conclusions
In summary, we have reported the isolation, identication and biological study of twenty compounds (1-13) including three new enantiomers (1a, 1b, 2a, 2b, 3a, 3b), two new ones (4a, 5a), and several of them inhibited PC12 cell damage induced by Okadaic Acid. Furthermore, compounds 6-7 were isolated from the genus Clausena for the rst time. The occurrence of alkaloids derivatives from C. lansium is in agreement with the previous ndings, 1-7 indicating that the isolation of these enantiomer compounds might be a useful chemotaxonomic for screening activity. The results of preliminary neuroprotective effect assays suggested that several isolated alkaloids derivatives showed moderate activity. Moreover, previous ndings exhibited that the carbazole, amide and quinolone alkaloids metabolites have neuroprotective effects and others biological activities such as anti-inammatory, hepatoprotective, cytotoxic 9,15-17 which indicating that the alkaloid compounds and their biological activities of C. lansium are worth studying in order to nd compounds with potential activity.
Experimental
Optical rotations were measured on a JASCO P2000 automatic digital polarimeter. UV spectra were recorded on a JASCO V-650 spectrophotometer, CD spectra were measured on a JASCO J-815 spectropolarimeter. IR spectra were recorded on a Nicolet 5700 spectrometer using an FT-IR microscope transmission method. NMR spectra were acquired with Bruker AVIIIHD 600, VNS-600, and Mercury-400 spectrometers in DMSO-d 6 and MeOH-d 6 . HRESIMS spectra were collected on an Agilent 1100 series LC/MSD ion trap mass spectrometer. MPLC system was composed of two C-605 pumps (Büchi), a C-635 UV detector (Büchi), a C-660 fraction collector (Büchi), and an ODS column (450 mm Â 60 mm, 50 mm, 400 g; YMC). Semi-preparative HPLC was conducted using a Shimadzu LC-6AD instrument with an SPD-20A detector and a Daicel Chiralpak AD-H column (250 Â 10 mm, 5 mm). Preparative HPLC was also performed on Fractions B 4-38 -B 4-42 was successively separated using preparative HPLC (detection at 210 nm, 18% CH 3 CN, 8 mL min À1 ) to yield 1 (20.3 mg, t R 37.50 min). Compound 1 was further separated by semipreparative chiral HPLC (n-hexane-2-propanol, 6 : 1, 3 mL min À1 ) to give 1a (9.1 mg, t R 57.63 min) and 1b (8.7 mg, t R 67.99 min). Fraction B 10 (5.1 g) was further separated by reversed-phase silica MPLC with MeOH-H 2 O (20-50%, 50 mL min À1 , 7 h) to afford B 10-1 -B 10-65 fractions. Fractions B 10-15 -B 10-20 were successively separated using preparative HPLC (detection at 210 nm, 8% CH 3 CN, 8 mL min À1 ) to yield 6a (8.2 mg, t R 58.35 min) and 6b (2.4 mg, t R 68.93 min).
Fraction C (197.3 g) was fractionated via silica gel column chromatography, eluting with CHCl 3 , EtOAc, n-BuOH, CH 3 COCH 3 , MeOH to afford ve fractions C 1 -C 5 . Fraction C 1 was further separated by PRP-512A with MeOH-H 2 O (35-70%) to afford C 1-1 -C 1-6 fractions. Fraction C 1-3 was further separated by reversed-phase silica MPLC with MeOH-H 2 O (35-55%, 50 mL min À1 , 6 h) to afford C 1-3-1 -C 1-3-12 fractions. Fraction C 1-3-11 was successively separated by Sephadex LH-20 and then using preparative HPLC (detection at 210 nm, 30% CH 3 CN, 8 mL min À1 ) to yield 5 (6.2 mg, t R 42.87 min), 7 (11.2 mg, t R 62.14 min) and 9 (24.4 mg, t R 51.17 min). Compound 5 was further separated by semipreparative chiral HPLC (n-hexane-2propanol, 3 : 1, 3 mL min À1 ) to give 5a (2.8 mg, t R 36.37 min) and 5b (2.1 mg, t R 45.78 min). Compound 7 was further separated by semipreparative chiral HPLC (n-hexane-2-propanol, 7 : 1, 3 mL min À1 ) to give 7a (4.8 mg, t R 19.85 min) and 7b (5.3 mg, t R 25.86 min). Fraction C 1-3-12 was successively separated by Sephadex LH-20 and then using preparative HPLC (detection at 210 nm, 29% CH 3 CN, 8 mL min À1 ) to yield 2 (5.2 mg, t R 48.14 min). Compound 2 was further separated by semipreparative chiral HPLC (n-hexane-2-propanol, 8 : 1, 3 mL min À1 ) to give 2a (2.8 mg, t R 25.81 min) and 2b (2.1 mg, t R 34.17 min). Fraction C 1-5 was further separated by reversed-phase silica MPLC with MeOH-H 2 O (35-55%, 50 mL min À1 , 6 h) to afford C 1-5-1 -C 1-5-8 fractions. Fraction C 1-5-6 was successively separated via silica gel column chromatography and then using preparative HPLC (detection at 210 nm, 32% CH 3 CN, 8 mL min À1 ) to yield 3 (10.7 mg, t R 53.75 min), 4 (9.2 mg, t R 39.05 min), 10 (3.1 mg, t R 52.10 min), 12 (2.4 mg, t R 49.16 min) and 13 (3.2 mg, t R 65.64 min). Compound 3 was further separated by semipreparative chiral HPLC (n-hexane-2-propanol, 9 : 1, 3 mL min À1 ) to give 3a (4.1 mg, t R 19.87 min) and 3b (3.9 mg, t R 25.12 min). Compound 4 was further separated by semipreparative chiral HPLC (n-hexane-2-propanol, 7 : 1, 3 mL min À1 ) to give 4a (1.5 mg, t R 21.98 min) and 4b (4.3 mg, t R 40.07 min). Fraction C 1-6 was further separated by reversed-phase silica MPLC with MeOH-H 2 O (35-55%, 50 mL min À1 , 6 h) to afford C 1-6-1 -C 1-6-10 fractions. Fraction C 1-6-2 was successively separated via silica gel column chromatography and then using preparative HPLC (detection at 210 nm, 30% CH 3 CN, 8 mL min À1 ) to yield 8 (5.2 mg, t R 33.31 min) and 11 (7.1 mg, t R 23.17 min).
(+)-(2 0 S,3 0 R)-Clauselansine A (1a 
Preparation of acetonide derivative (1c)
To determine the relative conguration of 1b, compound 1b (3 mg) was treated with 2,2-dimethoxypropane (1 mL) and pyridinium p-toluene sulfonate (1 mg), then stirred at 30 C for 5 h under N 2 circumstance. The reaction solution was evaporated in vacuo and puried by reversed-phase preparative HPLC using CH 3 Determination of absolute congurations of the 3 0 ,4 0 -diol unit in 1c
According to the published procedure, a 1 : 1.2 mixture of diol/ Mo 2 (OAc) 4 for 1c was subjected to CD measurements at a concentration of 0.1 mg mL À1 in anhydrous DMSO. The rst CD spectrum was recorded immediately aer mixing, and its time evolution was monitored until stationary (about 10 min aer mixing). The inherent CD was subtracted. The observed sign of the diagnostic band at around 310 nm in the induced CD spectrum was correlated to the absolute conguration of the 3 0 ,4 0 -diol unit.
Preparation of (R)-and (S)-MTPA eaters of 3a
A solution of 3a (1.31 mg) in dehydrated CH 2 Cl 2 (2 mL) was treated with (R)-(+)-a-methoxy-a-(triuoromethyl)phenylacetyl chloride [(R)-MTPA-Cl (10 mg)] in the presence of anhydrous pyridine, and the mixture was stirred at room temperature for 13 h. Aer cooling, the reaction mixture was poured into icewater and extracted with EtOAC. The EtOAC extract was successively washed with 5% aqueous HCl, saturated aqueous NaHCO 3 , and brine, then dried over Na 2 SO 4 and ltered. The solvent was removed from the ltrate under reduced pressure to afford a residue. The residue was puried by semi-preparative HPLC (C18 column, 3.0 mL min À1 , UV 210 nm, 80% CH 3 
Neuroprotection bioassays
Pheochromocytoma (PC12) cells were incubated in DMEM supplied with 5% fetal bovine serum and 5% equine serum as basic medium. PC12 cells in logarithmic phase were cultured at a density of 5000 cells per well in a 96-well microtiter plate. Aer 24 h incubation, the medium of the model group was changed to DMEM or basic medium with 15 mM Ab 25-35 for 48 h or basic medium with 50 nM OKA for 24 h. Test compounds dissolved in dimethyl sulfoxide (DMSO) were added to each well for >1000-fold dilution in the model medium at the same time. Each sample was tested in triplicate. Aer the incubation at 37 C in 5% CO 2 for 24 h, 10 mL of MTT (5 mg mL À1 ) was added to each well and incubated for another 4 h; then liquid in the wells was removed. DMSO (100 mL) was added to each well. The absorbance was recorded on a microplate reader (Bio-Rad model 550) at a wavelength of 570 nm. 37 Analysis of variance (ANOVA) followed by Newman-Keuls post hoc test were performed to assess the differences between the relevant control and each experimental group. p-Values of <0.05, <0.01, and <0.001 were regarded as statistically signicant. Data were expressed as mean AE SEM as indicated.
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